Considering taking Wegovy to lose weight? Here are the risks and benefits—and how it differs from OzempicConsidering taking Wegovy to lose weight? Here are the risks and benefits—and how it differs from Ozempic
The weight-loss drug Wegovy is now available in Australia. The weight-loss drug Wegovy is now available in Australia.
Scientists find way to starve breast cancer cellsScientists find way to starve breast cancer cells
Cancer cells have voracious appetites. And there are certain nutrients they can’t live without. Scientists have long hoped they might stop tumors in their tracks by cutting off an essential part of cancer cells’ diet. But these cells are crafty and often find a new way to get what they need. How? By reprogramming their metabolism and switching to backup food supplies.
T1D Stem Cell Success Story; Lilly’s Discount Tirzepatide Vials; Stelo Now AvailableT1D Stem Cell Success Story; Lilly’s Discount Tirzepatide Vials; Stelo Now Available
(MedPage Today) — A type 1 diabetes patient talked about her successful treatment with an investigational stem cell therapy currently in trials, noting that she hasn’t needed insulin since last August. (Washington Post) Eli Lilly said tirzepatide… (MedPage Today) — A type 1 diabetes patient talked about her successful treatment with an investigational stem Read More
Weight-loss drug Zepbound now in single-dose vials at half the priceWeight-loss drug Zepbound now in single-dose vials at half the price
Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers. Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the Read More
GLP-1 Agonists for Obesity—ReplyGLP-1 Agonists for Obesity—Reply
In Reply Dr Kurian and colleagues raise the option of surgical obesity treatments. These can be effective and cost-effective for individuals with appropriate indications. Yet many eligible patients opt for pharmacologic over surgical options. GLP-1 agonists also have far broader (and still expanding) indications, with at least 4-fold more US residents eligible. Identifying practical, effective, Read More
GLP-1 Agonists for ObesityGLP-1 Agonists for Obesity
To the Editor Dr Mozaffarian’s Viewpoint proposing a new solution to the cost and access issues plaguing GLP-1 agonists for weight loss contains serious misconceptions. To the Editor Dr Mozaffarian’s Viewpoint proposing a new solution to the cost and access issues plaguing GLP-1 agonists for weight loss contains serious misconceptions.
EHR Data Suggest Tirzepatide Outdoes Semaglutide for Weight LossEHR Data Suggest Tirzepatide Outdoes Semaglutide for Weight Loss
People with overweight or obesity who used tirzepatide lost about 7% more weight during the year after beginning treatment compared with those who used semaglutide, a recent observational study published in JAMA Internal Medicine found. However, the majority of people in both groups had lost 5% or more of their original body weight within 1 Read More
More Data About Risks, Benefits Might Change Breast Cancer Screening ChoiceMore Data About Risks, Benefits Might Change Breast Cancer Screening Choice
In April 2024, the US Preventive Services Task Force (USPSTF) recommended that women aged 40 to 74 years with an average risk of breast cancer undergo mammography screening every 2 years. This updated the USPSTF’s prior suggestion that women aged 40 to 49 years engage in shared decision-making with their clinician before deciding whether to be screened.
Clinical trial in Ireland challenges beliefs about Ozempic and similar new obesity treatmentsClinical trial in Ireland challenges beliefs about Ozempic and similar new obesity treatments
A study carried out in St Vincent’s University Hospital (SVUH) Dublin challenges the belief that weight-loss medications such as Ozempic, Wegovy or Monjaro work just by promoting satiety and making you eat less. A study carried out in St Vincent’s University Hospital (SVUH) Dublin challenges the belief that weight-loss medications such as Ozempic, Wegovy or Read More
Semaglutide-linked suicidal ideation identified in disproportionality analysisSemaglutide-linked suicidal ideation identified in disproportionality analysis
Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open. Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.